Big Ten Cancer Research Consortium
Greg Durm, MD, a medical oncologist, and researcher at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center, describes how researchers are testing if giving an immunotherapy drug called pembrolizumab following surgery is better than observation following surgery in adults with this type of cancer.
